 |
 |
|||||||
|
||||||||
|
||||||||
Agenda
Thursday, May 7 | Friday, May 8 | Saturday, May 9
| THURSDAY, MAY 7 | ||
| 7:00 am | Registration, Continental Breakfast & Exhibits | |
| SESSION I: | Autoimmune and Inflammatory Disorders from
Bench to Bedside Moderator: Leonard Calabrese, DO |
|
| 8:00 am | Welcoming Remarks - Leonard Calabrese, DO | |
| 8:15 am | R.J. Fasenmyer Annual Lectureship in Clinical Immunology: B Cell Biology 2009 - Peter Lipsky, MD | |
| 9:00 am | T Cell Trafficking in Health and Disease - Richard Ransohoff, MD | |
| 9:45 am | Break & Exhibits | |
| 10:15 am | T Cell Subsets in Health and Disease TH1, 2, 17 and Beyond - David Fox, MD | |
| 11:00 am | The Biology of the Inflammasome in Health and Disease: Implications for Therapy - Charles Dinarello, MD | |
| 11:45 am | Lunch | |
| SESSION II: | Biologics and Infections – Common and Rare Moderator: Christopher Ritchlin, MD |
|
| 1:00 pm | Defining Immunocompetancy in Biologic Trials - William St. Clair, MD | |
| 1:20 pm | Risks of Major Infections Across Agents - John Cush, MD | |
| 1:40 pm | Risks of Biologic Agents in the Surgical Setting: Global Recommendations - Jonathan Kay, MD |
|
| 2:00 pm | Break & Exhibits | |
| 2:30 pm | Biologics and Viral Hepatitis: Old Witch or Pretty Lady? - Nizar Zein, MD | |
| 2:50 pm | Vaccination Challenges in the Biologic Era - John Looney, MD | |
| 3:10 pm | PML & Biologic Therapy: Assessing Risks - Eamonn Molloy, MD | |
| 3:30 pm | Panel Discussion & Questions |
|
| 4:00 pm | Adjourn | |
| 7:00 pm |  |
GALA RECEPTION |
The RainForest at Cleveland Metroparks Zoo contains two acres of plants and wildlife found in rainforests around the world. The RainForest is a two-story domed, simulated biosphere that enables visitors to experience what it is like to walk through tropical regions of Central America, Africa, or Asia. Explore the RainForest during the Biologics Gala Event and enjoy viewing more than 600 animals, including birds, monkeys, reptiles, and colorful fish, that ply lagoons, swamps, and warm rivers. |
||
| Back to Top | ||
| FRIDAY MAY 8 | ||
| 7:30 am | Continental Breakfast & Exhibits | |
| SESSION III: | The Newer Agents Moderator: William St. Clair, MD |
|
| 8:30 am | Welcoming Remarks | |
| 8:45 am | Liver Abnormalities with Biologic DMARDs: Non-infectious Complications - Leonard Calabrese, DO | |
| 9:10 am | Next Generation of TNF Inhibitors - Edward Keystone, MD | |
| 9:35 am | Inhibiting IL6 in the Clinic: Risks and Benefits - Josef Smolen, MD | |
| 10:00 am | Break & Exhibits | |
| 10:30 am | Small Molecules for Treatment of Inflammatory Diseases: JAK-STAT-MAPK and More - Mark Genovese, MD | |
| 10:55 am | New Agents in Gastroenterology - Scott Plevy, MD | |
| 11:20 am | New Approaches to B Cell- and Lymph Node-Directed Therapy - William St Clair, MD | |
| 11:45 am | Panel Discussion & Questions | |
| 12:15 pm | Lunch | |
| SESSION IV: | Mini-Symposium Master Clinician Panel Moderator: Brian Mandell, MD, PhD |
|
| 1:15 pm | The Role of Biologics in Autoinflammatory Disease - Philip Hashkes, MD | |
| 1:45 pm | RA and Granulomatous Infection - John Cush, MD | |
| 2:15 pm | Rheumatoid Arthritis: What To Do About TNF Failures? - Edward Keystone, MD | |
| 2:45 pm | Break & Exhibits | |
| 3:15 pm | Patients with Pre-existing Malignancy - Jonathan Kay, MD | |
| 3:45 pm | Vasculitis and Biologics: A Continuing Conundrum - Eamonn Molloy, MD | |
| 4:15 pm | Hepatitis B and Inflammatory Diseases: How to Manage Biologics - Leonard Calabrese, DO & Nizar Zein, MD |
|
| 4:45 pm | Adjourn |
|
| Back to Top | ||
| SATURDAY, MAY 9 | ||
| 7:30 am | Continental Breakfast & Exhibits | |
| 8:20 am | Welcoming Remarks |
|
| SESSION V: | Cancer, Liver, Infections, Cardiovascular
Disease, and Other Biologic Agents Moderator: Nizar Zein, MD |
|
| 8:30 am | Epidemiology of Malignancies Across Biologic Agents - Jeffrey Greenberg, MD | |
| 8:55 am | Biologic Therapy and Pregnancy: What Are the Risks? - Nora Singer, MD | |
| 9:20 am | Risks of Cardiovascular Disease in Patients with Autoimmune and Inflammatory Disease - Elaine Husni, MD | |
| 9:45 am | Panel Discussion & Questions | |
| 10:00 am | Break & Exhibits | |
| 10:30 am | Empiric Therapy of Infection in Patients on Biologic Agents: Evidence-Based Guidelines - Thomas File, Jr., MD | |
| 10:55 am | Biologic Use in the US: Trends and Pharmacoeconomic Impact - Allan Gibofsky, MD | |
| 11:20 am | Dermatologic Uses of Biologic Drugs beyond Psoriasis and Psoriatic Arthritis - Michael P. Heffernan, MD | |
| 11:45 am | Panel Discussion & Questions | |
| 12:00 pm | Lunch | |
| Back to Top | ||
1:00 - 3:00 pm - Attendees must select of 1 of 3 breakout sessions |
||
Rheumatology | Moderator: Christopher Ritchlin, MD |
||
| 1:00 pm | Spondyloarthropathy: Therapeutic Implications of Advances in Pathogenesis - Christopher Ritchlin, MD | |
| 1:30 pm | Psoriatic Arthritis: QOL Issues and the Role of Biologics - Elaine Husni, MD | |
| 2:00 pm | Biologics and Systemic Vasculitis: What Is the Evidence in 2009? - Carol Langford, MD | |
| 2:30 pm | Panel Discussion & Questions | |
| 3:00 pm | Adjourn | |
Gastroenterology | Moderator: Nizar Zein, MD |
||
| 1:00 pm | Risks and Benefits of Biologics in IBD: Critical Management Decisions - Aaron Brzezinski, MD | |
| 1:30 pm | The Role and Risks of Natalizumab in the Treatment of Inflammatory Bowel Disease - Bret Lashner, MD | |
| 2:00 pm | The Potential Role for Biologic Agents in the Management of Nonalcoholic Fatty Liver Disease - Arthur McCullough, MD | |
| 2:30 pm | Panel Discussion & Questions | |
| 3:00 pm | Adjourn | |
Allied Health | Moderator: Elizabeth Kirchner, CNP |
||
| 1:00 pm | Immunology of Biologic Agents for Non-immunologists - Leonard Calabrese, DO | |
| 1:30 pm | Management of Infusion-Related Issues - Carmen Gota, MD | |
| 2:00 pm | Role of the Allied Health
Professional in Prescribing and
Monitoring Biologic Therapies / Case Studies - Elizabeth Kirchner, CNP, Tiffany Clark, RN MSN CNP |
|
| 2:45 pm | Panel Discussion & Questions | |
| 3:15 pm | Adjourn | |
| Back to Top | ||
